Published in Ann Neurol on September 01, 2002
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A (2010) 2.07
LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2004) 1.67
Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia (2010) 1.51
Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 1.48
Autoimmune encephalitis update. Neuro Oncol (2014) 1.27
Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome (2007) 1.25
Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol (2011) 1.22
A method for estimating penetrance from families sampled for linkage analysis. Biometrics (2006) 0.99
Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2008) 0.97
Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain. Hum Genet (2009) 0.97
Reexpression of LGI1 in glioma cells results in dysregulation of genes implicated in the canonical axon guidance pathway. Genomics (2009) 0.91
LGI1 gene mutation screening in sporadic partial epilepsy with auditory features. J Neurol (2005) 0.91
Somatic alterations in brain tumors. Oncol Rep (2008) 0.85
Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers. PLoS Comput Biol (2015) 0.83
LGI1: a gene involved in epileptogenesis and glioma progression? Neurogenetics (2005) 0.83
Function and mechanism of tumor suppressor gene LRRC4/NGL-2. Mol Cancer (2014) 0.82
Expression of the LGI1 gene product in astrocytic gliomas: downregulation with malignant progression. Virchows Arch (2003) 0.80
Altered language processing in autosomal dominant partial epilepsy with auditory features. Neurology (2008) 0.80
Mutant LGI1 inhibits seizure-induced trafficking of Kv4.2 potassium channels. J Neurochem (2012) 0.79
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol (2014) 0.78
Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro Oncol (2006) 0.78
Genetics of temporal lobe epilepsy: a review. Epilepsy Res Treat (2012) 0.78
Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat (2016) 0.78
Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus. Int J Physiol Pathophysiol Pharmacol (2012) 0.77
Genetics and epilepsy. Dialogues Clin Neurosci (2008) 0.77
Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects. Mol Syndromol (2016) 0.76
Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum. Sci Rep (2015) 0.76
Similarity of molecular phenotype between known epilepsy gene LGI1 and disease candidate gene LGI2. BMC Biochem (2010) 0.76
The genetics of temporal lobe epilepsy and implications for treatment. Epilepsy Curr (2007) 0.75
"Fold Here"-Chemical Correctors in the Treatment of Epilepsy. Epilepsy Curr (2015) 0.75
[Epilepsy and religion]. Tidsskr Nor Laegeforen (2011) 2.58
Nonadherence to treatment causing acute hospitalizations in people with epilepsy: an observational, prospective study. Epilepsia (2014) 2.08
A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol (2002) 1.77
Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J Physiol (2002) 1.56
Is elevated pre-ictal heart rate associated with secondary generalization in partial epilepsy? Seizure (2010) 1.45
Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol (2004) 1.40
[Changed health requirements regarding driver's licence for people with epilepsy]. Tidsskr Nor Laegeforen (2011) 1.39
Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet (2011) 1.39
[Anticonvulsants and drivers license--new guidelines should be revised]. Tidsskr Nor Laegeforen (2012) 1.38
Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res (2003) 1.26
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia (2005) 1.20
Familial temporal lobe epilepsy with aphasic seizures and linkage to chromosome 10q22-q24. Epilepsia (2002) 1.09
Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. Mol Pharmacol (2008) 1.07
The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins. FEBS Lett (2002) 1.06
Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia (2005) 1.03
Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr Genet (2003) 1.02
A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav (2005) 0.99
Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia (2007) 0.99
Second-generation antiepileptic drugs and pregnancy: a guide for clinicians. Expert Rev Neurother (2012) 0.97
The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol Dis (2005) 0.94
Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res (2008) 0.93
A new EF-hand containing gene EFHC2 on Xp11.4: tentative evidence for association with juvenile myoclonic epilepsy. Epilepsy Res (2005) 0.91
Speech-induced aphasic seizures in epilepsy caused by LGI1 mutation. Epilepsia (2005) 0.88
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch Neurol (2003) 0.87
Using gene-history and expression analyses to assess the involvement of LGI genes in human disorders. Mol Biol Evol (2005) 0.87
Neonatal seizures with tonic clonic sequences and poor developmental outcome. Epilepsy Res (2005) 0.87
A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia (2003) 0.86
Copy number variants in adult patients with Lennox-Gastaut syndrome features. Epilepsy Res (2013) 0.86
Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene. FEBS Lett (2009) 0.85
Tandem pore domain K(+)-channel TASK-3 (KCNK9) and idiopathic absence epilepsies. Am J Med Genet (2002) 0.84
Headaches add to the burden of epilepsy. J Headache Pain (2007) 0.81
Is dietary caffeine involved in seizure precipitation? Epilepsy Behav (2013) 0.81
Congenital myasthenia in Brahman calves caused by homozygosity for a CHRNE truncating mutation. Neurogenetics (2002) 0.81
Gorlin syndrome associated with small bowel carcinoma and mesenchymal proliferation of the gastrointestinal tract: case report and review of literature. BMC Cancer (2010) 0.80
Asymmetry of long-latency auditory evoked potentials in LGI1-related autosomal dominant lateral temporal lobe epilepsy. Epilepsia (2005) 0.80
Genotypic association of exonic LGI4 polymorphisms and childhood absence epilepsy. Neurogenetics (2003) 0.80
An easily performed group education programme for patients with uncontrolled epilepsy--a pilot study. Seizure (2003) 0.80
Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation. Arch Neurol (2003) 0.80
No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res (2003) 0.79
Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure (2008) 0.79
Distinct nuclear orientation patterns for mouse chromosome 11 in normal B lymphocytes. BMC Cell Biol (2014) 0.78
Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity. Acta Ophthalmol (2011) 0.78
A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely. Neurosci Lett (2007) 0.78
Congenital myasthenic syndromes. Semin Pediatr Neurol (2002) 0.77
SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features. Epilepsy Behav (2009) 0.77
Partial epilepsy with "ecstatic" seizures. Epilepsy Behav (2003) 0.77
Lamotrigine serum concentrations throughout the menstrual cycle--a study of 2 cases. Clin Neuropharmacol (2006) 0.77
Multiple cerebral cavernous malformations associated with extracranial mesenchymal anomalies. Neurosurg Rev (2007) 0.77
Temperature and pharmacological rescue of a folding-defective, dominant-negative KV 7.2 mutation associated with neonatal seizures. Hum Mutat (2011) 0.77
A novel missense mutation (N258S) in the KCNQ2 gene in a Turkish family afflicted with benign familial neonatal convulsions (BFNC). Turk J Pediatr (2008) 0.76
Nicotinic acetylcholine receptor subunits α4 and α5 associated with smoking behaviour and lung cancer are regulated by upstream open reading frames. PLoS One (2013) 0.76
Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors. Epilepsy Behav (2008) 0.76
[Epilepsy and pregnancy--drug use, seizure control, and complications]. Tidsskr Nor Laegeforen (2006) 0.75
The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice. Ther Drug Monit (2016) 0.75
Melanocortin-3-receptor promoter polymorphism associated with tuberculosis susceptibility does not influence protein expression. BMC Res Notes (2013) 0.75
Monozygous twins discordant for epilepsy. Ann Neurol (2002) 0.75
[Epilepsy and driving licenses]. Tidsskr Nor Laegeforen (2011) 0.75
Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia (2008) 0.75
In response: Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study. Epilepsia (2014) 0.75
Carbamazepine-induced cutaneous reactions: a simple assay to identify patients carrying the HLA-A*31:01 allele. Scand J Clin Lab Invest (2014) 0.75
Preface. Genetics of epilepsy. Prog Brain Res (2014) 0.75
The EEG response to photic stimulation is not increased in alcohol-related seizures. Clin Neurophysiol (2010) 0.75
[Dravet syndrome as a cause of epilepsy and learning disability]. Tidsskr Nor Laegeforen (2012) 0.75
[Epilepsy and rehabilitation]. Tidsskr Nor Laegeforen (2007) 0.75
Congenital myasthenic syndrome in cattle due to homozygosity for a truncating mutation in the acetylcholine receptor (AChR) epsilon-subunit gene. Ann N Y Acad Sci (2003) 0.75
[New definition of epilepsy]. Tidsskr Nor Laegeforen (2015) 0.75
Quantitative EEG in patients with alcohol-related seizures. Alcohol Clin Exp Res (2010) 0.75
Late onset of skin manifestations in Birt-Hogg-Dubé syndrome with FLCN mutation p.W260X. Acta Derm Venereol (2012) 0.75
[Lennox-Gastaut syndrome--course and treatment]. Tidsskr Nor Laegeforen (2011) 0.75
Mutation analysis of the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome. J Clin Psychopharmacol (2004) 0.75
Chance, serendipity and antiepileptic drugs. Tidsskr Nor Laegeforen (2017) 0.75
[Levetiracetam in the treatment of epilepsy]. Tidsskr Nor Laegeforen (2003) 0.75